Estimates Revisions ResMed Inc. OTC Markets
Stocks
RSMDF
AU000000RMD6
Advanced Medical Equipment & Technology
|
Delayed
OTC Markets
10:57:42 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 22.61 USD | -7.81% |
|
-7.81% | -15.41% |
| 07:08am | Resmed Insider Sold Shares Worth $1,110,191, According to a Recent SEC Filing | MT |
| 06:17am | Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
ResMed, Inc.(RMD)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
ResMed, Inc.(RMD)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
ResMed, Inc.(RMD)
EBIT
Dividend / Share (DPS)
Data source:
ResMed, Inc.(RMD)
Cash or Net Debt
- Stock Market
- Stocks
- RMD Stock
- RSMDF Stock
- Consensus ResMed Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
